Headline News

Jersey Shore University Medical Center Named Center of Excellence for Pancreas, Liver and Bile Duct Cancer Care

Hackensack Meridian Health Cancer Care today announced that Jersey Shore University Medical Center has earned The Joint Commission’s Gold Seal of Approval® for Center of Excellence for Pancreas, Liver, and Bile Duct Cancer Certification. The Gold Seal of Approval® is a symbol of quality that reflects an organization’s commitment to providing safe and effective patient care. The medical center is the first in New Jersey to receive this accreditation.

“Jersey Shore University Medical Center is pleased to receive this Disease-Specific Care Certification from The Joint Commission, the premier health care quality improvement and accrediting body in the nation,” noted Ronald Matteotti, M.D., medical director of the Hepatobiliary & Pancreatic Program and Chief of Hepatobiliary & Pancreatic Surgery at Jersey Shore University Medical Center. “This certification provides us with the framework to create a culture of excellence for those in our community. It is a huge accomplishment in recognition of our high-quality program and shows that patients with hepatobiliary cancers can receive the most advanced care right here in Monmouth and Ocean Counties, without the need to leave the area.”

Ronald Matteotti, M.D., FMH, FACS, ABIHM, DABS, is an internationally acclaimed double board certified surgeon who leads this challenging disease site with his team. He was instrumental in building the hepatobiliary program over the last five years.

“Our goal is to provide every patient an individualized treatment plan following NCCN guidelines, and to have a first treatment/workup decision within 24-48 hours from when the patient contacts our team. We have the capability and resources for a fast turn-around with streamlined processes and direct communication between our team and necessary specialists.”

Jersey Shore University Medical Center underwent a rigorous on-site review in February. Joint Commission experts evaluated compliance with national disease-specific care standards as well as with hepatobiliary cancer-specific requirements. Clinical practice guidelines and performance measures also were assessed.

To learn more about the Hepatobiliary / Pancreas program, please visit us online at www.hackensackmeridianhealth.org/services/cancer-care/cancer-services/hepatobiliary-and-pancreatic or call 732-776-4770.

Established in 2002 and awarded for a two-year period, The Joint Commission’s Disease-Specific Care Certification evaluates clinical programs across the continuum of care and addresses three core areas:
• Compliance with consensus-based national standards;
• Effective use of evidence-based clinical practice guidelines to manage and optimize care;
• An organized approach to performance measurement and improvement activities.

“Jersey Shore University Medical Center has thoroughly demonstrated a high level of care for patients with cancers of the pancreas, liver, and bile ducts,” said Patrick Phelan, executive director, Hospital Business Development, The Joint Commission. “We commend Hackensack Meridian Health Cancer Care for becoming a leader in hepatobiliary cancer care, potentially providing a higher standard of service for patients in its community with these challenging cancers.”

Cancers of the pancreas, liver, and bile ducts are highly complex and often advanced by the time they are diagnosed. They require a multidisciplinary team approach and advanced technologies to give patients the best chance of a good outcome.

At Hackensack Meridian Health Cancer Care in Monmouth and Ocean Counties, patients have access to comprehensive, compassionate care including world-class surgical, medical and radiation oncology expertise with access to clinical trials. We offer a multidisciplinary approach to care for all types of cancers and supportive programs and resources from diagnosis through treatment and after care.

PHOTO CAPTION:
The Hepatobiliary & Pancreatic Program team, from left is Jessica DiNapoli, MSPA, PA-C; Alexandria Shay, surgical coordinator; Ronald Matteotti, M.D., FACS, FMH, ABIHM, DABS, medical director, Hepatobiliary Surgery, Hackensack Meridian Health Cancer Care of Monmouth and Ocean counties and chief, Hepatobiliary & Pancreatic Surgery, Jersey Shore University Medical Center; Jillian Cassidy, MSPA, PA-C, and Dora Crowley, BSN, RN, oncology nurse navigator.

###

ABOUT HACKENSACK MERIDIAN HEALTH JERSEY SHORE UNIVERSITY MEDICAL CENTER
Located in Neptune, New Jersey, Hackensack Meridian Health Jersey Shore University Medical Center is a not-for-profit teaching hospital and the only Level II Trauma and Level II Pediatric Trauma Center in Monmouth and Ocean counties. It is home to K. Hovnanian Children’s Hospital – the first children’s hospital in Monmouth and Ocean counties. With more than 1,200 physicians and dental staff in 60 specialty areas, Jersey Shore University Medical Center’s team provides quality care in a patient-centered, environmentally-friendly setting.

The team’s commitment to excellence has earned Jersey Shore University Medical Center numerous accolades, including being named the #4 hospital in New Jersey by U.S. News & World Report for 2018-2019. The medical center’s clinical research program and longstanding commitment to medical education is evident through an affiliation with Hackensack Meridian School of Medicine at Seton Hall University and a new affiliation with St. George’s University School of Medicine. Jersey Shore University Medical Center serves as an academic center dedicated to advancing medical knowledge, training future physicians and providing the community with access to promising medical breakthroughs.

Jersey Shore University Medical Center’s programs and services have received numerous national recognition, including designation as high-performing in cardiac, stroke, surgical and oncology services.

Jersey Shore University Medical Center recently completed the HOPE Tower Project – a $265 million 10-story medical office building that provides a new healing outpatient experience. Guided by a patient-centered approach towards care, and informed by the latest medical breakthroughs, HOPE Tower includes advanced imaging services, a clinical academic center, innovative stimulation laboratory, state-of-the-art amphitheater, specialty physician offices, a nine-level parking garage, and a 58,000 square foot cancer facility. The new cancer facility features a range of comprehensive treatment options, including surgical specialties, medical oncology, and the most advanced radiation therapy and minimally invasive interventional therapies. Nurse navigators guide patients through every step and provide an extra layer of support and coordination.

The Joint Commission
Founded in 1951, The Joint Commission seeks to continuously improve health care for the public, in collaboration with other stakeholders, by evaluating health care organizations and inspiring them to excel in providing safe and effective care of the highest quality and value. The Joint Commission accredits and certifies more than 21,000 health care organizations and programs in the United States. An independent, nonprofit organization, The Joint Commission is the nation’s oldest and largest standards-setting and accrediting body in health care. Learn more about The Joint Commission at www.jointcommission.org.

The following are comments people have made about this post on Facebook. Shore News Network does not own these comments, nor does it have control over the moderation of these comments. Please report offensive and harmful comments directly to Facebook using the report comments feature in the comment dropdown box.







To Top